Cargando…
Response to Interleukin-17A Inhibitors According to Prior Biologic Exposures: A Danish Nationwide Study
Whether response to an interleukin (IL-17) inhibitor is different in patients with previous exposure to an IL-17 inhibitor compared with patients with exposure to biologics with other cytokine targets remains to be elucidated. Therefore, the aim of this study was to assess whether previous exposure...
Autores principales: | LOFT, Nikolai, EGEBERG, Alexander, ISUFI, Daniel, RASMUSSEN, Mads K., BRYLD, Lars E., DAM, Tomas N., AJGEIY, Kawa K., BERTELSEN, Trine, SKOV, Lone |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medical Journals Sweden, on behalf of the Society for Publication of Acta Dermato-Venereologica
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10680979/ https://www.ncbi.nlm.nih.gov/pubmed/37987625 http://dx.doi.org/10.2340/actadv.v103.12616 |
Ejemplares similares
-
Response to Biologics During the First Six Months of Therapy in Biologic-naïve Patients with Psoriasis Predicts Risk of Disease Flares: A Danish Nationwide Study
por: LOFT, Nikolai, et al.
Publicado: (2021) -
Predictors of Response to Biologics in Patients with Moderate-to-severe Psoriasis: A Danish Nationwide Cohort Study
por: SCHWARZ, Christopher Willy, et al.
Publicado: (2021) -
A nationwide population‐based cohort study of the incidence of severe and rare infections among adults with psoriasis in Denmark
por: Loft, Nikolai, et al.
Publicado: (2022) -
Comorbidities, socioeconomic status, drug use, and health care consumption in Danish women with psoriasis: A nationwide cross-sectional study
por: Johansen, Cæcilie Bachdal, et al.
Publicado: (2020) -
Development and internal validation of a diagnostic prediction model for psoriasis severity
por: Liljendahl, Mie Sylow, et al.
Publicado: (2023)